Richard brings decades of experience in the medtech industry, including leading GE’s magnetic Resonance division as President and CEO and holding several senior positions at Siemens over more than twenty years. Until recently he was CEO of Elekta, which treats cancer and brain disorders, and is currently CEO of Combinostics, which uses AI technology to manage the care pathway and improve the lives of patients with neurological disorders. He also serves as a member of the board of directors of IBA SA, a global market leader in proton therapy.